Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Management
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
3518 posts
Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Biotech
  • Earnings
  • General
  • Government
  • Health Care
  • News

Drugmakers, Health Authorities Discarding Several Million COVID-19 Vaccine Doses: Report

By Vandana Singh
Yesterday, 3:12 PM
Wall Street Journal reported that governments, drugmakers, and vaccination sites are discarding several unused COVID-19 vaccine doses amid declining…

AZN

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • News

Touchlight Inks Patent License Agreement With Pfizer

By Vandana Singh
Yesterday, 3:08 PM
Touchlight, a biotechnology company pioneering enzymatic DNA production, announced a non-exclusive patent license agreement with Pfizer Inc (NYSE:PFE). The pharma giant has…

PFE

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News

AstraZeneca’s COVID-19 Treatment Allowed In China’s Southern City: Reuters

By Vandana Singh
Yesterday, 3:06 PM
AstraZeneca Plc’s (NASDAQ:AZN) COVID-19 antibody cocktail has been cleared for use in a medical tourism zone in China’s southern…

AZN

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • M&A
  • Movers
  • News
  • Penny Stocks
  • Price Target
  • Reiteration
  • Small Cap
  • Trading Ideas

This Analyst Believes Precigen’s Non-Healthcare Divesture Removes Financial Overhang

By Vandana Singh
Yesterday, 12:44 PM
Yesterday, Precigen Inc (NASDAQ: PGEN) agreed to sell its non-healthcare subsidiary to URUS.

PGEN

Read More
1 minute read
  • Earnings
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

T2 Biosystems Shares Slide As Interim Q2 Sales Trail Consensus

By Vandana Singh
Yesterday, 10:21 AM
T2 Biosystems Inc (NASDAQ:TTOO) expects Q2 FY22 revenues of $5.8 million – $6.1 million, below the consensus of $6.87 million.…

TTOO

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • Movers
  • News
  • Trading Ideas

Sarepta Reports One Heart Inflammation Case In Duchenne Gene Therapy Trial

By Vandana Singh
Yesterday, 9:55 AM
Sarepta Therapeutics Inc (NASDAQ:SRPT) shared new functional data across multiple studies from the SRP-9001 (delandistrogene moxeparvovec) program for Duchenne muscular dystrophy. …

RHHBF

Read More
1 minute read
  • Biotech
  • General
  • Health Care
  • News
  • Penny Stocks

Immunome’s COVID-19 Cocktail Retains Neutralizing Activity Against Omicron Subvariants

By Vandana Singh
Yesterday, 9:28 AM
Immunome Inc (NASDAQ:IMNM) has announced that its cocktail (IMM-BCP-01) retained activity against the BA.4/5 and BA.2.12.1 subvariants in lab testing.  IMM-BCP-01…

IMNM

Read More
3 minute read
  • Biotech
  • FDA
  • General
  • Health Care
  • Movers
  • News
  • Penny Stocks
  • Trading Ideas

The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer’s Drug Due In January, FDA Reviews Roche’s Lymphoma Candidate, Rare Pediatric Tag For Kazia’s Pediatric Brain Cancer Candidate

By Vandana Singh
Yesterday, 9:14 AM
Here's a roundup of top developments in the biotech space over the last 24 hours:

AMTI

Read More
1 minute read
  • General
  • M&A
  • Movers
  • News
  • Small Cap
  • Trading Ideas

Why Resolute Forest Products Shares Are Rallying Today?

By Vandana Singh
Yesterday, 7:29 AM
Through its wholly-owned subsidiary Domtar Corporation, the Paper Excellence Group has agreed to acquire Resolute Forest Products Inc (NYSE:RFP). Fairfax Financial Holdings Limited,…

RFP

Read More
1 minute read
  • FDA
  • General
  • Health Care
  • News

FDA Temporarily Suspends Banning Order On Juul’s E-Cigarettes

By Vandana Singh
Yesterday, 7:13 AM
The FDA temporarily suspended its ban on sales of the popular e-cigarette maker Juul, backed by Altria Group Inc

MO

Posts navigation

1 2 … 352 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service